Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Incorporating Prescription Drugs Into Affordable Care Act Risk Adjustment

Bibliographic Data

ID9098763
AuthorsGregory C Pope (0000-0003-2274-7095, RTI International, Ellicott City, Waltham, MA, corresponding author), Andrew Pearlman (0000-0003-1199-5421, RTI International, Ellicott City, Waltham, MA, corresponding author), Melvin J Ingber (0000-0003-4848-932X, Centers for Medicare & Medicaid Services, CCIIO, Baltimore, MD), John Kautter (0000-0002-2530-4727, RTI International, Ellicott City, Waltham, MA, corresponding author), Kelly Drury (Centers for Medicare & Medicaid Services, CCIIO, Baltimore, MD), Krutika Amin (Centers for Medicare & Medicaid Services, CCIIO, Baltimore, MD), James Wrocklage (0000-0002-3737-0537, RTI International, Ellicott City, Waltham, MA, corresponding author)
Year2020
Volume58
Issue6
Pages504-510
Publication date2020-06-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueMedical Care (JOURNAL)
Journal identifiersISSN: 0025-7079 • E-ISSN: 1537-1948
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0000000000001302
PMID32011425
OpenAlexW3005103542
LanguageEN
References cited2

BACKGROUND: The 2010 Patient Protection and Affordable Care Act reformed the individual and small group health insurance markets and established a risk adjustment program to create a level playing field for competition. A new set of predictive models for measuring enrollee risk across plans was developed for the Patient Protection and Affordable Care Act-reformed markets, referred to as the Department of Health and Human Services Hierarchical Condition Category (HHS-HCC) models. Beginning in 2018, selected prescription drug classes were added to the models as risk markers. OBJECTIVE: We describe the motivations, concerns, methodology, and results of adding prescription drug utilization to the HHS-HCC models. METHODS: Separate HHS-HCC models are estimated by enrollee age and plan actuarial value. We defined and added 10 prescription drug classes, called RXCs, to the HHS-HCC adult models. RESULTS: Using selected RXCs alongside demographic and diagnostic indicators yielded modest overall improvement in HHS-HCC models' predictive power. Also, adding RXCs captures the higher costs of enrollees taking certain expensive pharmaceuticals and allows imputation of diagnoses for enrollees utilizing a drug but lacking the associated diagnosis. CONCLUSIONS: Including selected drugs in risk adjustment improved the models' predictive power. In addition, inclusion of selected drugs may discourage insurers from using formulary and drug benefit design to avoid enrollment of patients taking high-cost drugs, such as for HIV, multiple sclerosis, and rheumatoid arthritis, and improve access for enrollees taking these drugs. Adding RXCs also may improve plan risk measurement for plans with less complete diagnosis reporting

Actuarial science · Business · Cost sharing · Family medicine · Formulary · Health care · Medical prescription · Predictive power · Prescription drug · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management · Medication Adherence and Compliance · Medicine · Nursing · Pharmacology

  • The Medicaid Rx Model

    Todd Gilmer, Richard Kronick et al.•Medical Care•2001

Citation velocityhistorical
Highly citedNo

Tools

Open DOI
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae